<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919997</url>
  </required_header>
  <id_info>
    <org_study_id>AMC-060</org_study_id>
    <secondary_id>U01CA121947</secondary_id>
    <secondary_id>CDR0000629624</secondary_id>
    <nct_id>NCT00919997</nct_id>
  </id_info>
  <brief_title>Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men</brief_title>
  <official_title>HPV Infection in Indian HIV-Seropositive Men Who Have Sex With Men (MSM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AIDS Malignancy Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The EMMES Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AIDS Malignancy Consortium</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Gathering information about human papilloma virus (HPV) infection in HIV-positive
      men who have sex with men may help doctors learn more about the disease.

      PURPOSE: This clinical trial is studying HPV infection in HIV-positive Indian men who have
      sex with men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Describe the prevalence of penile, anal, and oral human papilloma virus (HPV) infection
           in HIV-seropositive Indian men who have sex with men.

        -  Determine the spectrum of HPV types at these anatomic sites in these patients.

        -  Determine the distribution of strain variants of HPV 16, 18, and 31 at these anatomic
           sites in these patients.

        -  Describe risk factors for penile, anal, and oral HPV infection in these patients.

      OUTLINE: This is a multicenter study.

      Patients complete interviewer-administered questionnaires on demographics, native place,
      socioeconomic status, medical history, numbers of sexual partners and sexual practices,
      circumcision status, and risk factors for oral malignancies and human papilloma virus (HPV),
      including oral sex, smoking or chewing tobacco, drug use, oral hygiene, and tooth loss.

      Patients undergo cell sample collection from the penis, scrotum, anus, and mouth, and saliva
      sample collection for HPV DNA testing by PCR. Patients also undergo blood sample collection
      to measure CD4+ count and HIV viral load by FACS and PCR.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detectable human papilloma virus DNA in the penis, anus, or mouth</measure>
    <time_frame>Study entry</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distribution of strain variants of HPV 16, 18 and 31</measure>
    <time_frame>Study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM</measure>
    <time_frame>Study entry</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">302</enrollment>
  <condition>Nonneoplastic Condition</condition>
  <condition>Precancerous Condition</condition>
  <arm_group>
    <arm_group_label>Specimen collection</arm_group_label>
    <description>Single group study. Blood, saliva, anal cytology, and penile cytology samples, and questionnaire responses will be collected from participants at a single study visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>DNA analysis</intervention_name>
    <description>Anal pap smear, penile pap smear, blood collection, and saliva collection at a single study visit for HPV DNA analysis.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>polymerase chain reaction</intervention_name>
    <description>Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fluorescence activated cell sorting</intervention_name>
    <description>Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <description>Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>study of socioeconomic and demographic variables</intervention_name>
    <description>Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>study of high risk factors</intervention_name>
    <description>Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.</description>
    <arm_group_label>Specimen collection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Anal cytology Penile cytology Saliva Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-1 infected men who have sex with men from Mumbai and Vellore, India, who are age 18 or
        older.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  HIV-1 infection, as documented by ELISA and confirmed by a second testing method
             (e.g., western blot, HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second
             antibody test by a method other than ELISA)

             - If prior documentation and confirmation of HIV-1 infection is not available, two
             licensed rapid HIV tests are allowed

          -  Must have had receptive or insertive anal intercourse with another man within the past
             6 months

        PATIENT CHARACTERISTICS:

          -  Speaks Hindi (in Mumbai) or Tamil (in Vellore)

          -  No active drug or alcohol use or dependence that, in the opinion of the site
             Investigator, would interfere with adherence to study requirements

          -  No history of a sex-change operation that would preclude collection of penile or
             scrotal specimens

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Palefsky, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dilip Mathai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christian Medical College and Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashok Row Kavi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Humsafar Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Helen Diller Family Comprehensive Cancer Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2009</study_first_submitted>
  <study_first_submitted_qc>June 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>human papilloma virus infection</keyword>
  <keyword>HIV infection</keyword>
  <keyword>HIV Infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Precancerous Conditions</mesh_term>
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

